ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,264.97
-0.24%
Dow Jones
38,477.03
-0.54%
US Dollar vs MXN
17.5081
3.14%
Brent Oil
78.655
-2.66%
Bitcoin
68,873.33
1.66%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC
  6. Oncology Pharma Inc (CE) (ONPH)

  7. Oncology Pharma Inc (CE) (ONPH) Noticias

ONPH

Oncology Pharma (CE) (ONPH)

Oncology Pharma Inc (CE)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:USOTC:ONPH
FechaHoraFuenteTítuloSímboloCompañía
12/07/202207:36InvestorsHub NewsWireOncology Pharma Conducting Interviews and Presentations with Investors to Pursue Next Steps to Forward The Development Process of Nanoemulsion Drug Delivery SystemUSOTC:ONPHOncology Pharma Inc (CE)
29/06/202208:23InvestorsHub NewsWireOncology Pharma Conducting All The Preparations to Take Steps to Forward The Development Process of Nanoemulsion Drug Delivery SystemUSOTC:ONPHOncology Pharma Inc (CE)
08/06/202207:17InvestorsHub NewsWireOncology Pharma Announces: Initial Feasibility Study of the Nanoemulsion Drug Delivery System is Complete and Results Have Met the Threshold for Moving Forward To the Next Steps of DevelopmentUSOTC:ONPHOncology Pharma Inc (CE)
09/05/202207:48InvestorsHub NewsWireOncology Pharma Advances Progress on Multiple Fronts Including Advanced Attention to Connect2Trials' Commercial DevelopmentUSOTC:ONPHOncology Pharma Inc (CE)
13/04/202207:45InvestorsHub NewsWireOncology Pharma Completes Feasibility Phase of its Licensed Nanoemulsion Drug Delivery System to Treat CancerUSOTC:ONPHOncology Pharma Inc (CE)
02/03/202207:03InvestorsHub NewsWireOncology Pharma Reports on Progress with Ribera SolutionsUSOTC:ONPHOncology Pharma Inc (CE)
23/02/202207:00InvestorsHub NewsWireOncology Pharma Releases Further Feasibility Studies, Data and CapacitiesUSOTC:ONPHOncology Pharma Inc (CE)
17/02/202207:16InvestorsHub NewsWireOncology Pharma Expands on Feasibility Studies and DataUSOTC:ONPHOncology Pharma Inc (CE)
14/02/202207:11InvestorsHub NewsWireOncology Pharma, Inc. and Regen BioPharma, Inc. Announce Intent to Jointly Fast Track Development of Modified mRNA anti-Cancer VaccineUSOTC:ONPHOncology Pharma Inc (CE)
08/02/202207:30InvestorsHub NewsWireOncology Pharma Gives Update on Technology, Formulation and Data CreationUSOTC:ONPHOncology Pharma Inc (CE)
10/01/202207:15InvestorsHub NewsWireOncology Pharma's New Year UpdateUSOTC:ONPHOncology Pharma Inc (CE)
17/12/202107:11InvestorsHub NewsWireOncology Pharma Meeting Towards Future DevelopmentsUSOTC:ONPHOncology Pharma Inc (CE)
09/12/202107:04InvestorsHub NewsWireOncology Pharma Year End Review and OutlookUSOTC:ONPHOncology Pharma Inc (CE)
30/11/202107:02InvestorsHub NewsWireOncology Pharma Research and VisionUSOTC:ONPHOncology Pharma Inc (CE)
08/11/202107:00InvestorsHub NewsWireOncology Pharma Reveals Plans for Development of Lead Cancer Drug CandidateUSOTC:ONPHOncology Pharma Inc (CE)
28/10/202110:11InvestorsHub NewsWireOncology Pharma, Inc. Gives Update on Ongoing Work and ProgressUSOTC:ONPHOncology Pharma Inc (CE)
15/10/202119:12StockInvest.usHigh volatility in Oncology Pharma Inc. stock price on Friday which ended trading at $13.95USOTC:ONPHOncology Pharma Inc (CE)
15/10/202109:51InvestorsHub NewsWireOncology Pharma, Inc. Has Engaged a PCAOB Audit Firm Looking Towards Moving the Company Towards a Senior ListingUSOTC:ONPHOncology Pharma Inc (CE)
12/10/202107:30InvestorsHub NewsWireOncology Pharma, Inc. Update on PCAOB Audit Selection Process and License AgreementUSOTC:ONPHOncology Pharma Inc (CE)
04/10/202119:09StockInvest.usBig movements in Oncology Pharma Inc. stock price on Monday moving 40.14% between high and lowUSOTC:ONPHOncology Pharma Inc (CE)
16/09/202119:08StockInvest.usHigh volatility in Oncology Pharma Inc. stock price on Thursday which ended trading at $11.35USOTC:ONPHOncology Pharma Inc (CE)
13/09/202107:30InvestorsHub NewsWireOncology Pharma, Inc. Has Received the Committed Funding to Perform All Necessary IND-Enabling Preclinical Work for Its First Lead Candidate, a Dactinomycin Nanoemulsion Drug ProductUSOTC:ONPHOncology Pharma Inc (CE)
26/08/202119:08StockInvest.usHigh volatility in Oncology Pharma Inc. stock price on Thursday which ended trading at $20.38USOTC:ONPHOncology Pharma Inc (CE)
25/08/202119:12StockInvest.usVolatile ride for Oncology Pharma Inc. stock price on Wednesday moving between $14.02 and $17.99USOTC:ONPHOncology Pharma Inc (CE)
24/08/202119:09StockInvest.usBig movements in Oncology Pharma Inc. stock price on Tuesday moving 10.33% between high and lowUSOTC:ONPHOncology Pharma Inc (CE)
23/08/202119:10StockInvest.usHigh volatility in Oncology Pharma Inc. stock price on Monday which ended trading at $15.00USOTC:ONPHOncology Pharma Inc (CE)
23/08/202107:30InvestorsHub NewsWireOncology Pharma's Co-Development Agreement Pursues Strategic and Direct ObjectivesUSOTC:ONPHOncology Pharma Inc (CE)
20/08/202119:10StockInvest.usHigh volatility in Oncology Pharma Inc. stock price on Friday which ended trading at $15.42USOTC:ONPHOncology Pharma Inc (CE)
19/08/202107:00InvestorsHub NewsWireOncology Pharma, Inc. Executes Co-Development Agreement with NanoSmart Pharmaceuticals, Inc.USOTC:ONPHOncology Pharma Inc (CE)
12/08/202119:11StockInvest.usRed day on Thursday for Oncology Pharma Inc.USOTC:ONPHOncology Pharma Inc (CE)
 Showing the most relevant articles for your search:USOTC:ONPH

Su Consulta Reciente

NASDAQ
EEIQ
EpicQuest Education
NASDAQ
FXQGAX
Strategic Income Select ...
NASDAQ
AAXRJXX
Citigroup Global Markets...
BITMOT
869297
Romania Tf 3% Fb31 Usd
BIT
P1T8J4
BNP Paribas Issuance
LSE
84HW
Home Grp.8t%37
NASDAQ
ASAX
Astrea Acquisition
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados